News

As 2026 draws to a close, the U.S. state privacy law landscape looks nothing like it did even a year ago. If your company collects, uses, or sells personal data — and virtually every company does — this is not a year you...

Biotech deal activity in the first half of 2026 reflects a market recalibrating after two years of tightened capital — and the structures reflect that caution. Option-to-acquire arrangements remain the dominant Big...

FDA regulates AI-enabled diagnostic and clinical decision support tools as Software as a Medical Device (SaMD) when intended to diagnose, treat, mitigate, or prevent a disease or condition. The applicable clearance pathway...

Companies using SMS and MMS messaging for marketing, transactional alerts, or customer communications face a growing and actively enforced patchwork of legal obligations. The Telephone Consumer Protection Act (TCPA) remains...

While the U.S. still lacks a comprehensive federal privacy law, the Federal Trade Commission has steadily expanded its enforcement footprint — and companies that assume federal oversight is limited to the FTC’s...